Symbol: |
PDE9A
|
Description: |
phosphodiesterase 9A [Source:HGNC Symbol;Acc:8795]
|
Location: |
Chr21:44073746-44195619[+]
|
CRmiRSNP:
~ Export ~
|
Records:null
Compound |
CRmiRSNP |
SNP_sig |
Model |
Molecule |
Mol_sig |
Type |
Model : M1-Allele, M2-Recessive, M3-Additive, M4-Dominant
Total:0 Current:1
[First] [Prev] [Next] [Last]
|
Compound:
~ Export ~
|
Records:118
Gene |
Compound |
Gen_sig |
Exp_pattern |
PDE9A |
C.I. 37559 |
0.007 |
Up |
PDE9A |
NSC 56614 |
0.025 |
Down |
PDE9A |
RAPAMYCIN PRODRUG |
0.005 |
Up |
PDE9A |
Rapamycin prodrug, Mono-(28)-N,N-diethylpropionate-, hydrochloride salt |
0.049 |
Up |
PDE9A |
Benzo[1,2-c:4,5-c']dipyrrole-1,3,5,7(2H,6H)-tetraimine |
0.014 |
Up |
PDE9A |
Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester |
0.039 |
Up |
PDE9A |
Naphth[2,3-d]thiazole-4,9-dione, 2-[(2-methylphenyl)amino]- |
0.029 |
Down |
PDE9A |
ANTINEOPLASTIC-625543 |
0.008 |
Down |
PDE9A |
Naphthalene-1,2-dione, 1,2-dihydro- 4-[(2-phenylethyl)amino]- |
0.045 |
Down |
PDE9A |
23,27-Epoxy-3H-pyrido[2,1-c] [1,4]oxaazacyclohentriacontine-1,5,11,28,29-pentone-, 1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31, 32,33,34,34a-tetracosahydro- 27-hydroxy-10,21-dimethoxy-3-[2-[3-methoxy-4-[1-oxo- 3-(dimethylamino)propoxy]cyclohexy |
0.044 |
Up |
PDE9A |
1,4-BIS(DIETHYLAMINO)-5,8-DIHYDROXY ANTHRAQUINON |
0.025 |
Up |
PDE9A |
NSC 650958 |
0.032 |
Down |
PDE9A |
2-(2-(Dimethylamino)ethylamino)naphthazarin |
0.032 |
Down |
PDE9A |
NSC 662119 |
0.048 |
Down |
PDE9A |
NSC 664955 |
0.019 |
Down |
Expression pattern: Sensitivity / Resistance
Total:8 Current:2
First Prev Next Last 
|
SNP:
~ Export ~
|
Records:8
Total:1 Current:1
[First] [Prev] [Next] [Last]
|
miRNA:
~ Export ~
|
Records:60
Total:4 Current:1
[First] [Prev]  Next Last 
|